Compare KNSA & CCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KNSA | CCC |
|---|---|---|
| Founded | 2015 | 1980 |
| Country | United Kingdom | United States |
| Employees | N/A | 2185 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.1B |
| IPO Year | 2018 | N/A |
| Metric | KNSA | CCC |
|---|---|---|
| Price | $51.58 | $4.60 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 8 |
| Target Price | ★ $60.86 | $8.94 |
| AVG Volume (30 Days) | 461.7K | ★ 9.7M |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 225.00 | N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $677,564,000.00 | N/A |
| Revenue This Year | $37.48 | $10.22 |
| Revenue Next Year | $17.87 | $8.58 |
| P/E Ratio | $182.48 | ★ N/A |
| Revenue Growth | ★ 60.09 | N/A |
| 52 Week Low | $26.27 | $4.08 |
| 52 Week High | $59.87 | $8.68 |
| Indicator | KNSA | CCC |
|---|---|---|
| Relative Strength Index (RSI) | 50.21 | 43.23 |
| Support Level | $44.95 | $4.08 |
| Resistance Level | $59.87 | $5.09 |
| Average True Range (ATR) | 1.93 | 0.23 |
| MACD | -0.24 | 0.02 |
| Stochastic Oscillator | 52.85 | 17.86 |
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
CCC Intelligent Solutions Holdings Inc is a provider of cloud, mobile, AI, telematics, hyperscale technologies, and applications for the property and casualty insurance economy. The company's SaaS platform connects trading partners, facilitates commerce, and supports mission-critical, AI-enabled digital workflows. It operates in a single segment being Domestic segment, which provides SAAS platform for the P&C insurance economy and derives revenues from providing customers with software subscriptions to the platform in addition to providing professional services and non-software services. The company has its presence in the United States and China. The majority of the revenue is generated from the United States.